Abstract Background Medication administration to patients with an enteral feeding tube (EFT) is complex and prone to errors. Community pharmacists may be ideally placed to provide training and advice on this topic in individual patients as well as in institutions supplied by the pharmacy. Objective To assess community pharmacists' knowledge on guideline recommendations regarding medication preparation and administration through EFT. Method Knowledge of guideline recommendations was assessed using a 15-item self-administered online questionnaire (April-June 2014). Questions reflected key aspects of guideline recommendations on medication administration via EFT. All graduated community pharmacists from the Dutch-speaking part of Belgium were eligible for participation. Results A total of 105 community pharmacists completed the questionnaire. Median self-perceived knowledge of medication administration via EFT was 2 (on a 0-10 scale). On average 5.2 (SD 2.6) out of the 15 questions were answered correctly. Strikingly, the ability to select suspensions in a list of liquid medications and knowledge on crushability of solid dosage forms were low. Conclusion Our findings demonstrate that pharmacists' knowledge on correct medication administration via EFT is too limited to be able to provide good advice to EFT patients or their caregivers. Tailored training on this topic is needed.
Introduction
Medication administration through an enteral feeding tube (EFT) is prone to errors such as inappropriate dosage form selection, crushing non-crushable drugs, and wrong administration techniques. These errors can lead to reduced drug efficacy, increased adverse effects, and tube obstruction [1] . To reduce these risks, guidelines for the safe administration of drugs via EFT have been available for many years [1, 2] . Because of the frequent patient contacts upon prescription filling and because of their specific medication-related expertise concerning drug formulations, adverse effects, etc., community pharmacists may be ideally placed to provide training and advice in the application of these guidelines in individual patients as well as in institutions supplied by the community pharmacy. However, there are currently no data available on the actual level of knowledge about drug administration through EFT among community pharmacists. This is important as this determines the quality of their advice.
Aim of the study
The present study aimed at investigating community pharmacists' knowledge on current international guidelines for medication administration via EFT.
Ethical approval
According to local regulations, no ethical approval was needed since no clinical data were collected.
Method Study design and participants
This observational questionnaire study was carried out from April to June 2014 in Belgium. All graduated community pharmacists from the Dutch-speaking part of Belgium were eligible for participation. Consent to participate was indicated by completion of the questionnaire.
Data collection
A 15-item self-administered questionnaire was developed by two pharmacists and a fourth-year pharmacy student. Each question reflected a key point from the guideline recommendations on medication administration via EFT [1, 2] (Table 1) .
The questionnaire was pilot tested with three community pharmacists. In addition to the guideline-related items, background information on the participating pharmacists was collected (gender, age, work experience, whether they are consulted by patients with EFT, whether they deliver medication to residential care facilities (RCF) for individuals with intellectual disability who also have EFT, and whether they received postgraduate training concerning medication administration via EFT). Participants were also asked to rate their self-perceived level of knowledge on medication administration via EFT on a scale of 0 (= no knowledge) to 10 (= excellent knowledge). At the end of the questionnaire each participant had to indicate whether he had used information sources during completion. The questionnaire was made electronically accessible using Qualtrics software (Qualtrics Inc., Provo, UT). All five local pharmacists' professional organisations were asked to forward an e-mail to their members describing the purpose of the study and including a web link to the questionnaire (a total of approximately 4470 pharmacists).
Data analysis and statistical analysis
For each item of the questionnaire, the number of participants answering correctly was determined. For questions with more than one correct answer (Q3, Q4, Q5, Q7, Q10, Q14), participants had to find all the correct answers to get the question right.
Answers to the open-ended question (Q15) were categorized. We also calculated a total score per participant by giving one point to each correct response, resulting in a total score ranging from 0 to 15. Descriptive statistical analysis was performed. The effect of participant characteristics on the total score was evaluated using scatter plots for continuous variables (age, work experience, and self-perceived knowledge) and independent sample t-tests for categorical variables (being consulted by EFT patients, postgraduate training received concerning medication administration via EFT, and use of information sources during questionnaire completion). All statistical analyses were performed using SPSS 21.0 for Windows (SPSS Inc., Chicago, IL, USA). A P value\0.05 was considered statistically significant.
Results
One hundred and five pharmacists completed the questionnaire (estimated response rate 2 %). The median age of the participating pharmacists was 35 years, with a range of 22-66 years, and 74 of them (70 %) were female. Median years of working experience in community pharmacy was 10 (range 0-42 years). Thirty-three pharmacists (31 %) had EFT patients among their patients, and five of these (5/ 33) also delivered medication to RCFs for people with intellectual disabilities. Only 2 pharmacists (2 %) already completed a postgraduate training on medication administration via EFT, 74 pharmacists (70 %) perceived a need for training on this topic, and 48 (46 %) were willing to give training in RCFs. Median self-perceived knowledge of medication administration via EFT was 2 (on a scale of 0-10 scale).
From a maximum score of 15, the participating pharmacists obtained on average 5.2 (SD 2.6, range 0.0-12.0) or 35 % (SD 18 %, range 0-80 %). The proportion of pharmacists answering correctly to the individual questions is shown in Table 1 . The guideline recommendations concerning water as the preferred flush solution (Q11) and 
Which of the following tablets should NOT be crushed when administered by gastric feeding tube (multiple answers possible) 63 (60 %)
e. Carbamazepine CR the preparation of hard gelatin capsules (Q2) were known best. Least known items included: when to flush the EFT (Q10), the minimum recommended backrest elevation (Q13), and recognizing drugs with risk of poor bioavailability when administered through a jejunostomy tube (Q14). No significant differences in total scores were found 
9.
What is the recommended procedure regarding enteral feeding when medication needs to be administered? 33 (31 %) a. Administration of the enteral feeding can be continued during medication administration b. The enteral feeding only needs to be stopped before medication administration c. The enteral feeding needs to be stopped, and the feeding tube needs to be flushed before medication is administered . Yes, the backrest should be elevated to an angle of at least 30°d
. Yes, the backrest should be elevated to an angle of 90°e
. Yes, the backrest should be elevated, but I do not know to which angle f. I do not know 14. Which of the following drugs can have a decreased bioavailability when administered through a jejunostomy tube? (multiple answers possible) For questions with multiple correct answers (Q3, Q4, Q5, Q7, Q10, Q14), participants had to find all the correct answers to get the question right; the numbers in italic indicate the percentage of participants that ticked the corresponding correct answer option for the investigated categorical variables [being consulted by EFT patients (P = 0.159), postgraduate training received concerning medication administration via EFT (P = 0.212), and use of information sources during questionnaire completion (P = 0.071)], nor did scatter plots show correlation between the continuous variables (age, work experience, and self-perceived knowledge) and total score. Ten percent of the participants reported to have used information sources during questionnaire completion, which included (1) an online database of the Belgian Centre for Pharmacotherapeutic Information [3] (n = 4), (2) an online Belgian database about crushing solid dosage forms [4] (n = 4), (3) the DelphiCare Ò database (a drug information database) [5] (n = 2), (4) summary of product characteristics (n = 1), (5) handbook of drug administration via enteral feeding tubes [2] (n = 1), and (6) Google (n = 1).
Discussion

Main findings
Pharmacists' knowledge related to medication administration through EFT was poor. However, participants recognized their lack of knowledge (self-perceived knowledge of 2 on a 0-10 scale). A striking finding is that only a minority of participants was able to select suspensions, which need to be shaken before use to ensure correct dosing, out of a list of commercially available liquid dosage forms. One of the suspensions on this list was the frequently dispensed domperidone suspension Motilium Ò . Far better, yet still rather low, is the number of participants identifying all non-crushable drugs (i.e. the sustained release dosage forms Depakine Chrono Ò and Carbamazepine CR Ò , and the enteric coated Losec Mups Ò ), hence suggesting a limited knowledge on solid dose formulation coding.
Interpretation of findings in relation to previous studies
Our results were comparable to the findings in other settings with other health care professionals where it was reported that acute care nurses [6] and staff members of RCFs for people with intellectual disabilities (i.e. mainly non-medically educated staff) [7] had insufficient knowledge related to medication administration through EFT as well. In their pre-post study Dashti-Khavidaki et al. [6] found that less than one-third of the acute care nurses correctly responded to the questions dealing with the recognition of dosage forms, tube flushing, and medication preparation. In our previous study examining knowledge of staff members of RCFs for people with intellectual disabilities [7] a similar questionnaire was used. When comparing these results with the observation in the present study, pharmacists scored substantially better than RCF staff members on questions related to the crushability of tablets. The most surprising difference however, was that pharmacists scored worse on the question dealing with the identification of suspensions in a list of commercially available liquid dosage forms. Another important difference between these two samples was that, even though total scores were low in both samples, pharmacists knew they lack knowledge on this topic, whereas RCF staff members thought their knowledge was good.
Previous research in the hospital setting [6, 8] and in an RCF for people with intellectual disabilities [9] demonstrated that educational intervention programs that were led by (clinical) pharmacists, improved practice and knowledge of personnel involved in medication preparation and administration to patients with EFT. However, when taking into account the findings of the present study, community pharmacists will need proper training before being able to provide qualitative education and advice on this topic.
Limitations
Main limitation of our study is that only a small number of pharmacists completed the questionnaire. The combination of a typically low response rate to web-questionnaires, the voluntary participation and hence high probability that mainly pharmacists that are interested in this topic participated in the questionnaire, make it difficult to generalise our findings to the wider pharmacist community. However, this limitation suggests that our data reflect an overestimation of knowledge amongst the general population of community pharmacists. Another limitation may be that, compared to the total population of Belgian pharmacists, sex distribution in our sample was similar (70 % female vs. 74 % in total population, P = 0.157), but mean age was significantly lower (mean of 37 vs. 44 in the total population, P = 0.000). Since care for special patient populations has gained more attention in Belgian pharmacy education over the last decade, this adds to the conjecture that pharmacist knowledge is overestimated in this study.
Conclusion
Our findings demonstrate that community pharmacists' knowledge on correct medication administration via EFT is insufficient to be able to provide good advice to EFT patients or their caregivers. Tailored training on this topic in both basic and postgraduate training of pharmacists is needed, as well as access to up-to-date and reliable information sources and educational material.
